Romosozumab Efficacy in Postmenopausal Women With No Prior Fracture Who Fulfill Criteria for Very High Fracture Risk

McClung, M. R., Betah, D., Deignan, C., Shi, Y., Timoshanko, J., & Cosman, F. (2023). Romosozumab Efficacy in Postmenopausal Women With No Prior Fracture Who Fulfill Criteria for Very High Fracture Risk. Endocrine Practice, 29(9), 716–722. https://doi.org/10.1016/j.eprac.2023.06.011
Authors:
Michael R McClung
Donald Betah
Cynthia Deignan
Yifei Shi
Jen Timoshanko
Felicia Cosman
Affiliated Authors:
Felicia Cosman
Columbia Affiliation:
Subjects:
Bone Density Conservation Agents (MeSH)
Osteoporosis, Postmenopausal (MeSH)
Osteoporotic Fractures (MeSH)
Author Keywords:
american association of clinical endocrinology (aace)
bone mineral density (bmd)
osteoporosis
treatment sequence
very high fracture risk (vhfr)
elink
Publication Type:
Article
Unique ID:
10.1016/j.eprac.2023.06.011
PMID:
37406858
DOI:
10.1016/j.eprac.2023.06.011
Journal:
Endocrine Practice
Publication Date:
Data Source:
PubMed
Source Link:
View PubMed Record
View Scopus Record

Record Created: